Product
RAD011
2 clinical trials
1 indication
Indication
Prader-Willi SyndromeClinical trial
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study of RAD011 (Cannabidiol Oral Solution) for the Treatment of Patients With Prader- Willi SyndromeStatus: Terminated, Estimated PCD: 2022-10-06
Clinical trial
A Phase 3, Open-label Extension Study to Assess the Safety, Tolerability, and Efficacy of RAD011 (Cannabidiol Oral Solution) in Patients With Prader-Willi SyndromeStatus: Withdrawn, Estimated PCD: 2025-08-01